Skip to content

Clinical Trial of Wrist Blood Pressure Monitor in Conformance With the EN ISO 81060-2:2019/A1:2020 Standard

Clinical Trial on the Effectiveness of Blood Pressure Function of Wrist Blood Pressure Monitor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05482035
Enrollment
88
Registered
2022-08-01
Start date
2022-02-16
Completion date
2022-03-31
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Brief summary

The accuracy and safety of wrist blood pressure (model: MLY-B10) is evaluated according to the requirement of EN ISO 81060-2:2019/A1:2020.

Interventions

DEVICEwrist blood pressure monitor

Comparing blood pressure measured by wrist blood pressure monitor with mercury sphygmomanometer .

Sponsors

Huawei Device Co., Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Subjects should voluntarily participate in the clinical trial and sign the informed consent form. 2. Subjects must be willing and able to follow the investigation procedures. 3. Subjects are over 18 years old whose wrist circumference should be within 13.0-20.0 cm.

Exclusion criteria

1. Subjects with serious arrhythmias (atrial fibrillation, atrial flutter, ventricular flutter, ventricular fibrillation, ventricular tachycardia, borderline tachycardia, sinus arrest, pathological sinus syndrome, pacemaker rhythm) showed by electrocardiogram during screening period. 2. Subject with prior allergy to nylon, fluororubber, thermoplastic polyurethane elastomer (TPU), or polyvinyl chloride (PVC) materials. 3. Subjects with prior arterial obstructive disease or arteritis. 4. Subjects who had previously undergone mastectomy. 5. Subjects with wound or wrist inflammation were measured. 6. Subjects who are receiving intravenous infusion, blood transfusion, or other catheters at the site of measurement. 7. Subjects who had eaten, drank, smoked or exercised vigorously in the 30 minutes prior to the study. 8. Subjects who have participated in other clinical trials within 30 days that may affect this trial. 9. Subjects who the investigator consider inappropriate to attend the trial.

Design outcomes

Primary

MeasureTime frameDescription
mean difference of systolic blood pressure30 minutesmean difference of systolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
mean difference of diastolic blood pressure30 minutesmean difference of diastolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
standard deviation of the difference of systolic blood pressure30 minutesstandard deviation of the difference of systolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
standard deviation of the difference of diastolic blood pressure30 minutesstandard deviation of the difference of diastolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026